Microneedle patches may improve hyperpigmentation treatment with better skin delivery and minimal side effects. Read more.

As more and more research hints at the potential therapeutic uses of psychedelics, finding new ways to deliver the powerful drugs has taken on new interest. For example, the active component of ...

The global transdermal patch market, projected to grow from $1.61 billion in 2024 to $2.35 billion by 2029, is expected to reach $18 billion by 2030, expanding at a CAGR of 7.8%. The U.S. leads with a ...

Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Transdermal Skin Patches Market by Types, Application, Distribution Channel, and Region with Company Analysis 2025-2033" report has been added to ...

An innovative delivery method for human immunodeficiency virus medications has been developed through use of a transdermal patch, the first of its kind to treat HIV. An innovative delivery method for ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.

March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eight years ago, I wrote about a startup trying to deliver cancer ...

It was a severe vitamin D3 deficiency that introduced Yashovardhan Kanodia, 35, co-founder of East Star Financial Advisors in Kolkata to vitamin patches. Racked by aches and pains in his body, he ...

Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...

It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...